The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
Clinical trial NCT04433845 · UNKNOWN
Trial details
- NCT number
- NCT04433845
- Sponsor
- Sheppard Pratt Health System
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2023-01-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.